Editor's Picks
Editor's Picks
Market Movers: Corporate Events Drive Significant Stock Gains and Investor Interest
July 13, 2026Biogen (NASDAQ: BIIB) Stock Rises on Positive Alzheimer’s Drug News and Analyst ‘Buy’ Rating
July 13, 2026Analyst firm Jefferies maintained a “Buy” rating for Biogen, signaling confidence in the biotechnology stock. The U.S. FDA approval of an at-home starting dose for LEQEMBI enhances patient convenience for...
Editor's Picks
We will not share your information & you can unsubscribe at any time. You agree to our terms of service & privacy policy. You agree to receive emails & correspondence from Nextmemealert.
